SHENZHEN, China, April 26 Winner Medical Group Inc.(Nasdaq: WWIN; "Winner Medical" or the "Company"), a leading manufacturer ofmedical dressings, medical disposables and non-woven PurCotton(R) materialsfor the medical and consumer products industries, announced today that itintends to offer shares of its common stock in an underwritten public offering.Roth Capital Partners is acting as the lead manager for the public offering.
Winner Medical previously filed a registration statement, together withthe accompanying base prospectus, with the Securities and Exchange Commission("SEC") in connection with the offering, which was declared effective by theSEC on March 18, 2010. Investors are advised to carefully consider theinvestment objectives, risks and expenses of Winner Medical Group beforeinvesting. The base prospectus contains certain information about WinnerMedical and should be read carefully before investing. A prospectus supplementdescribing the particular terms of the offering will be filed with the SEC andwill form a part of the effective registration statement. When available,copies of the prospectus supplement and the accompanying base prospectus maybe obtained from the SEC's web site at http://www.sec.gov , or from RothCapital Partners, LLC, 24 Corporate Plaza, Newport Beach, CA 92660, firstname.lastname@example.org or via fax at (949) 720-7227.
This press release shall not constitute an offer to sell, or thesolicitation of an offer to buy, any securities of Winner Medical Group, norshall there be any sale of these securities in any state or jurisdiction inwhich such offer, solicitation or sale would be unlawful prior to registrationor qualification under the securities laws of any such state or jurisdiction.
About Winner Medical:
Winner Medical is a leading manufacturer and the largest exporter byvolume in the medical dressing industry in China. Headquartered in Shenzhen,the Company has eight wholly-owned operating subsidiaries and four jointventures with over 5,000 employees. The Company engages in the manufacturing,sale, research and development of medical care products, wound care products,home care products and PurCotton(R) products, a nonwoven fabric made from 100%natural cotton. The products are sold worldwide, with Europe, the UnitedStates, China and Japan serving as the top four markets. The Company currentlyholds more than sixty patents and patent applications for various products andmanufacturing processes and is one of the few Chinese companies licensed bythe U.S. Food and Drug Administration (FDA) to ship finished, sterilizedproducts directly to the United States market. To learn more about WinnerMedical, please visit Winner Medical's web site at:http://ir.winnermedical.com .
This press release contains certain statements that may include"forward- looking statements" within the meaning of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the Securities ExchangeAct of 1934, as amended. All statements, other than statements of historicalfact included herein are "forward-looking statements" including statementsregarding Winner Medical and its subsidiary companies' business strategy,plans and objectives and statements of non-historical information. Theseforward-looking statements are often identified by the use of forward-lookingterminology such as "believes," "expects" or similar expressions, involveknown and unknown risks and uncertainties. Although Winner Medical believesthat the expectations reflected in these forward-looking statements arereasonable, they do involve assumptions, risks and uncertainties, and theseexpectations may prove to be incorrect. You should not place undue reliance onthese forward-looking statements, which speak only as of the date of thispress release. Winner Medical's actual results could differ materially fromthose anticipated in these forward- looking statements as a result of avariety of factors, including those discussed in Winner Medical's periodicreports that are filed with and available from the Securities and ExchangeCommission. All forward-looking statements attributable to Winner Medical orpersons acting on its behalf are expressly qualified in their entirety bythese factors. Other than as required under the securities laws, WinnerMedical does not assume a duty to update these forward-looking statements.For more information, please contact: Company: Peng Zhai Investor Relations Manager Winner Medical Group Inc. Tel: +86-755-2806-6858 +86-755-2813-8888 x691 Email: email@example.com Web: http://ir.winnermedical.com Investors: Scott Powell HC International, Inc. Tel: +1-917-721-9480 Email: firstname.lastname@example.org Web: http://www.hcinternational.net
SOURCE Winner Medical Group Inc.